← Bausch Health Companies Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $9.7b | $8.7b | $8.4b | $8.6b | $8.0b | $8.4b | $8.1b | $8.8b | $9.6b | $10.3b | |
| Cost of Goods and Services Sold | $2.6b | $2.5b | $2.4b | $2.4b | $2.2b | $2.4b | $2.4b | $2.6b | $2.8b | $3.0b | |
| Gross Profit (Calculated) (derived) | $7.1b | $6.2b | $6.0b | $6.3b | $5.8b | $6.0b | $5.8b | $6.2b | $6.8b | $7.3b | |
| Operating Income (Loss) | ($566.0m) | $102.0m | ($2.4b) | ($203.0m) | $676.0m | $450.0m | $454.0m | $963.0m | $1.5b | $1.8b | |
| Additional Financial Items | |||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($41.0m) | $107.0m | $23.0m | $8.0m | ($30.0m) | $7.0m | ($8.0m) | ($52.0m) | ($47.0m) | ($52.0m) | |
| Gain (Loss) on Investments | $0 | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) Related to Litigation Settlement | ($59.0m) | ($226.0m) | $27.0m | ($1.4b) | ($422.0m) | ($356.0m) | ($9.0m) | $53.0m | ($220.0m) | ($61.0m) | |
| Goodwill, Impairment Loss | $1.1b | $312.0m | $2.3b | $0 | — | $469.0m | $824.0m | $493.0m | — | $145.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($1.8b) | ($2.0b) | ($1.5b) | ($2.4b) | ($410.0m) | ($323.0m) | $64.0m | ($382.0m) | ($596.0m) | ($743.0m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $1.8b | $934.0m | ($1.0b) | ($129.0m) | ($390.0m) | $167.0m | $367.0m | |
| Net Income (Loss) Attributable to Parent | ($2.4b) | $2.4b | ($4.1b) | ($1.8b) | ($560.0m) | ($948.0m) | ($225.0m) | ($592.0m) | ($46.0m) | $157.0m | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($2.4b) | $2.4b | ($4.1b) | ($1.8b) | ($560.0m) | ($948.0m) | ($225.0m) | ($592.0m) | ($46.0m) | $157.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.0m | $0 | $4.0m | $5.0m | $1.0m | $11.0m | $13.0m | ($19.0m) | ($26.0m) | ($37.0m) | |
| Earnings Per Share, Basic | ($6.94) | $6.86 | ($11.81) | ($5.08) | ($1.58) | ($2.64) | ($0.62) | ($1.62) | ($0.13) | $0.42 | |
| Earnings Per Share, Diluted | ($6.94) | $6.83 | ($11.81) | ($5.08) | ($1.58) | ($2.64) | ($0.62) | ($1.62) | ($0.13) | $0.42 | |
| Weighted Average Number of Shares Outstanding, Basic | 347.3m | 350.2m | 351.3m | 352.1m | — | 358.9m | 362.0m | 364.9m | 368.0m | 370.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 347.3m | 351.8m | 351.3m | 352.1m | — | 358.9m | 362.0m | 364.9m | 368.0m | 375.0m | |
| Selling, General and Administrative Expense | $2.8b | $2.6b | $2.5b | $2.6b | $2.4b | $2.6b | $2.6b | $2.9b | $3.3b | $3.4b | |
| Other Nonoperating Income (Expense) | ($73.0m) | $353.0m | $21.0m | ($1.4b) | ($454.0m) | ($373.0m) | ($35.0m) | ($28.0m) | ($247.0m) | ($142.0m) | |
| Business Combination, Acquisition Related Costs | $2.0m | — | — | $8.0m | $0 | $11.0m | $29.0m | $24.0m | $4.0m | $9.0m | |
| Costs and Expenses | $10.2b | $8.6b | $10.8b | $8.8b | $7.4b | $8.0b | $7.7b | $7.8b | $8.1b | $8.5b | |
| Current Income Tax Expense (Benefit) | $241.0m | $166.0m | $327.0m | $128.0m | $224.0m | ($51.0m) | $271.0m | $215.0m | $170.0m | $115.0m | |
| Interest Expense, Debt | — | — | — | $1.6b | $1.5b | $1.4b | $1.5b | $1.3b | $1.4b | $1.6b | |
| Income Tax Expense (Benefit) | ($27.0m) | ($4.1b) | ($10.0m) | ($54.0m) | ($375.0m) | ($87.0m) | $83.0m | $221.0m | $239.0m | $247.0m | |
| Other Operating Income (Expense), Net | ($73.0m) | $353.0m | $21.0m | ($1.4b) | ($454.0m) | ($373.0m) | ($35.0m) | ($28.0m) | ($247.0m) | ($142.0m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.